IDEAS home Printed from https://ideas.repec.org/p/wip/wpaper/24.html
   My bibliography  Save this paper

Sources of biopharmaceutical innovation: An assessment of intellectual property

Author

Listed:
  • Michael S. Kinch

    (Washington University in St Louis, St Louis, MO, USA.)

  • Julio Raffo

    (Economics and Statistics Division, World Intellectual Property Organization, Geneva, Switzerland.)

Abstract

An analysis of FDA-approved new molecular entities reveals dynamism in terms of new innovation. An assessment of the first patent for each drug reveals that the pharmaceutical industry, particularly large, established companies in North America, tend to dominate the field. Over the past 10-15 years, European and Asian organizations have begun to close the gap. A dynamic inventive environment in drug discovery is suggested by the fact that NMEs for biologics or awarded to biotechnology companies often have inventors from the pharmaceutical and academic sectors. Whereas inventors continue to found biotechnology companies at a steady rate, recent trends suggest these inventors more often come from the private sector.

Suggested Citation

  • Michael S. Kinch & Julio Raffo, 2015. "Sources of biopharmaceutical innovation: An assessment of intellectual property," WIPO Economic Research Working Papers 24, World Intellectual Property Organization - Economics and Statistics Division.
  • Handle: RePEc:wip:wpaper:24
    as

    Download full text from publisher

    File URL: http://www.wipo.int/edocs/pubdocs/en/wipo_pub_econstat_wp_24.pdf
    Download Restriction: no
    ---><---

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Fernando Gascón & Jesús Lozano & Borja Ponte & David Fuente, 2017. "Measuring the efficiency of large pharmaceutical companies: an industry analysis," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 18(5), pages 587-608, June.

    More about this item

    Keywords

    FDA; Patent; Intellectual Property; Firm founder.;
    All these keywords.

    NEP fields

    This paper has been announced in the following NEP Reports:

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:wip:wpaper:24. See general information about how to correct material in RePEc.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Economics and Statistics Division). General contact details of provider: https://edirc.repec.org/data/ewipoch.html .

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service hosted by the Research Division of the Federal Reserve Bank of St. Louis . RePEc uses bibliographic data supplied by the respective publishers.